A. Kemena

Statistics

Publications

Citations

318

H-Index

Active since

1984

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

A. Kemena is an author at The University of Texas MD Anderson Cancer Center specializing in pharmacology, chemotherapy, and fludarabine-based regimens.

Publications per year

1984–1994

Publications

Fludarabine infusion potentiates arabinosylcytosine metabolism in lymphocytes of patients with chronic lymphocytic leukemia.

Varsha Gandhi, A. Kemena, Michael J. Keating et al. · PubMed · 1992 · 94 citations

Medicine, Pharmacology, Pharmacotherapy +14

Cellular Pharmacology of Fludarabine Triphosphate in Chronic Lymphocytic Leukemia Cells During Fludarabine Therapy

Varsha Gandhi, A. Kemena, Michael J. Keating et al. · Leukemia & lymphoma/Leukemia and lymphoma · 1993 · 60 citations

Medicine, Pharmacokinetics, Pharmacology +13

Phase II Clinical Trial of Fludarabine in Chronic Lymphocytic Leukemia on a Weekly Low-Dose Schedule

A. Kemena, Susan O’Brien, Hagop Kantarjian et al. · Leukemia & lymphoma/Leukemia and lymphoma · 1993 · 44 citations

Medicine, Oncology, Pharmacology +14

A sensitive fluorescence assay for quantitation of fludarabine and metabolites in biological fluids

A. Kemena, Mechelle Fernandez, John G. Bauman et al. · Clinica Chimica Acta · 1991 · 39 citations

Life Sciences, Pharmacokinetics, Pharmacology +14

Fludarabine phosphate: a new active agent in hematologic malignancies.

Michael J. Keating, Susan O’Brien, William Plunkett et al. · PubMed · 1994 · 34 citations

Medicine, Hematology, Pharmacology +10

1–5 of 8